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The aims of this study were to determine whether dis-
parities in waiting list outcomes exist for Hispanics and
African Americans during the post-MELD era, and to
investigate interactions between disparities and geog-
raphy. Scientific Registry of Transplant Recipients data
were used to compare Hispanics and African Ameri-
cans to Caucasians listed between 2003 and 2008. End-
points included (i) receipt of a liver transplant and (ii)
death or removal from the waiting list for being too sick
or medically unsuitable. Adjustment for possible con-
founders was performed using multivariate Cox regres-
sion, with adjustment for geographic variation using a
fixed-effects multilevel model. In multivariate analysis,
African Americans have similar hazard of transplan-
tation and death/removal as Caucasians during the
post-MELD era. However, Hispanics are less likely to re-
ceive a transplant than Caucasians despite adjustment
for potential confounders (HR 0.80, 95% CI 0.77–0.83),
while having a similar hazard of death/removal. This
effect disappeared after adjusting for unequal regional
distribution of Hispanics, who represent 8% of patients
in donation service areas (DSAs) having median wait-
ing times of ≤155 days versus 19% in DSAs with me-
dian waiting times of >155 days. In conclusion, dispar-
ities in liver transplantation exist for Hispanics during
the post-MELD era, caused by geographic variation in
organ availability.
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Introduction
Since the supply of organs available for liver transplantation
is limited, equitable allocation of these organs represents
a major concern for the transplant community and society
as a whole. Unfortunately, significant racial and ethnic dis-
parities in access to liver transplantation have been well
documented at every stage of the liver transplant process:
referral for medical evaluation for transplant (1), placement
on the transplant list (2) and actual receipt of a transplant
once listed (3–5). For example, one study which analyzed
data from 1994 to 1998 found that African Americans were
33% less likely to receive a transplant than Caucasians
once placed on the waiting list (2). These disparities may
have been partially caused by the organ allocation policies
during that period, which emphasized time spent on the
waiting list and subjective measures of disease severity
such as degree of encephalopathy and ascites, or need for
inpatient care (6).
Because of these concerns, the Institute of Medicine re-
leased a report in 2000 calling for organs to be allocated on
the basis of objective measures of disease severity (7). This
led to implementation of the model for end-stage liver dis-
ease (MELD) allocation policy in 2002 for deceased donor
liver transplantation among adults in the United States.
The MELD system is based entirely on laboratory data to
accurately predict the probability of death within 3 months.
While this system provides a completely objective means
for prioritizing patients on the waiting list for liver transplan-
tation (8), the distribution and availability of organs is still
subject to geographic variation (9), which could contribute
to racial and ethnic disparities. A recent study analyzing
data from 2002 to 2006 found equal rates of transplan-
tation between African Americans and Caucasians, and
concluded that implementation of the MELD allocation sys-
tem was associated with improvements in racial disparities
(10). However, this study did not include Hispanics, who
are the largest and fastest growing minority group in the
United States (11) and have higher rates of hepatitis C than
Caucasians or African Americans (12). Therefore, the aim
of this study was to determine whether disparities in wait-
ing list outcomes exist for Hispanics during the post-MELD
era, and to investigate interactions between disparities and
geographic location.
Methods
The data source was the Scientific Registry of Transplant Recipients (SRTR)
Standard Analysis File as of February 2, 2009, of all adults (≥18) placed on
the waiting list for liver transplantation in the United States (US) between
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January 2003 and January 2008. These dates were chosen to allow 5 years
of analysis data during the post-MELD era. Race and ethnicity were deter-
mined by the individual transplant centers, with the largest categories being
White (74%), Hispanic (13%) and African American (8%). Waiting list out-
comes for African Americans and Hispanics were compared to Caucasians
among 47 363 subjects; Missing data for some variables resulted in a final
sample size of 47 070.
The primary endpoints of this study were (i) transplantation and (ii) removal
from the waiting list because of death, being too sick or being medically
unsuitable for a transplant. Patients removed from the waiting list for other
reasons, such as being too well or transfer to another center, were cen-
sored at the time of removal. The two endpoints of interest, transplant
and death/removal, represent competing risks which can confound survival
analysis (13). However, it is unknown whether these competing risks might
affect the analysis of disparities by race and ethnicity. In order to evaluate
this, we constructed several competing risk models which varied the as-
sumptions about baseline hazard functions and differences in hazard ratios
by outcome type (14). In addition, cumulative incidence plots were gen-
erated using nonparametric competing risk methods (15). None of these
models showed significant differences in disparities compared with simple
Cox regression. Therefore, Cox regression was used for the remainder of
the comparative analyses.
Clinical and demographic characteristics were compared between Cau-
casians versus African Americans, and Caucasians versus Hispanics. The
chi-square test was used for categorical data and t-test was used for contin-
uous data. Variables included age at listing, gender, blood type, etiology of
liver disease (viral, alcohol, hepatocellular carcinoma or other) and available
comorbidities which have been shown to affect posttransplant survival (16).
Severity of liver disease was determined by the laboratory MELD score,
which was treated as a time-varying covariate to reflect changing MELD
scores while on the waiting list. Multivariate Cox regression was then used
to adjust for these variables in the analysis of differences in waiting list
outcomes between African Americans and Hispanics versus Caucasians.
We hypothesized that geographic variability may contribute to disparities,
since African Americans and Hispanics may be more likely to live in do-
nation service areas (DSAs) with more severe organ shortage. In order to
test this hypothesis, we considered median waiting time in each DSA as a
surrogate measure of organ shortage. DSAs were ranked by their median
waiting time and divided at the midpoint into two categories labeled ‘Me-
dian wait-time >155 days’ and ‘Median wait-time ≤155 days. The proportion
of patients identified as African American and Hispanic was calculated for
each DSA category, and the chi-square test was used to determine statis-
tically significant differences relative to Caucasians. Finally, the multivariate
Cox regression on waiting list outcomes was repeated, adjusting for geo-
graphic variability in organ shortage using a multilevel model. The Hausman
specification test for appropriateness of a random-effects estimator was
statistically significant, so results are presented using a fixed-effects model
(stratified by DSA) with robust standard errors (17).
Results
During the post-MELD era (January 2003–January 2008),
there were 50 047 adults listed for liver transplantation,
of whom 4195 (8%) were African American, 6854 (13%)
were Hispanic and 36 314 (73%) were Caucasian.
The unadjusted hazard ratios (HR) of transplantation and
death/removal for African Americans and Hispanics com-
Table 1: Unadjusted analysis of waiting list outcomes for African
Americans and Hispanics, compared to Caucasians during the
post-MELD era
Post-MELD








HR = hazard ratio; CI = confidence interval; MELD = model for
end-stage liver disease.
pared to Caucasians are shown in Table 1. African Ameri-
cans were more likely than Caucasians to receive a trans-
plant and more likely to die/be removed (HR 1.32, p <
0.001 and 1.30, p < 0.001 respectively), while Hispanics
were less likely than Caucasians to receive a transplant but
equally likely to die/be removed (HR 0.82, p < 0.001 and
1.03, p = 0.32 respectively). Cumulative incidence plots
for the two endpoints are shown in Figure 1.
Clinical and demographic differences between the racial
and ethnic groups are shown in Table 2. African Ameri-
cans had more severe liver disease than Caucasians, with
median listing MELD scores of 18 versus 15, respectively.
African Americans also tended to be younger, were less
commonly male and had differing distributions of blood
type and etiology of liver disease compared to Caucasians.
When adjusting for these differences in multivariate anal-
ysis, the hazard of transplantation and death/removal for
African Americans was no longer significantly different
from that of Caucasians, as shown in Table 3. Hispanics dur-
ing the post-MELD era were similar in age and severity of
liver disease compared to Caucasians, as shown in Table 2.
However, Hispanics were less commonly male, were more
likely to have comorbidities and had differing distributions
of blood type and etiology of liver disease compared to
Caucasians. Despite adjustment for all of these variables,
Hispanics still appear less likely to receive a transplant (HR
0.80, p < 0.001) during the post-MELD era, while their
hazard of death/removal was no longer statistically differ-
ent from that of Caucasians as shown in Table 3.
Comparison of geographic differences between the groups
revealed that Hispanics make up a much larger proportion
of the waiting list in DSAs with median wait-time >155
days compared to those with median wait-time ≤155 days,
as shown in Figure 2. Results from the multilevel Cox re-
gression indicate that there was significant correlation in
waitlist outcomes according to DSA (likelihood ratio = 5110
for transplantation and 299 for removal, p < 0.001 for both).
This indicates that the DSA a patient was listed in con-
tributed significantly to the probability of these outcomes,
despite adjustment for multiple potential confounders.
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Figure 1: Cumulative incidence of primary endpoints: (A) transplantation, and (B) death or removal for being too ill or medically
unsuitable. Cumulative incidence calculated using the nonparametric competing risk method.
After adjusting for these DSA-level effects in the multilevel
model, the hazards of transplantation and death/removal
for Hispanics were no longer significantly different from
those of Caucasians, as shown in Table 4. African
Table 2: Clinical and demographic characteristics according to
racial and ethnic group during the post-MELD era
African
Caucasian American Hispanic








Hepatitis C 37% 41%∗ 44%∗
Alcohol 16% 5%∗ 16%
HCC 4% 5%# 4%
Other 43% 49%∗ 36%
Comorbidities 9% 8%# 8%#
Blood group
A 40% 28%∗ 31%∗
B 11% 18%∗ 9%#
AB 4% 3%∗ 1%#
O 45% 51%∗ 59%∗
Median age at listing 53 52∗ 53
Gender (% male) 66% 58%∗ 62%∗
#p < 0.05 versus Caucasians.
∗p < 0.001 versus Caucasians.
HCC = hepatocellular carcinoma.
Comorbidities include chronic obstructive pulmonary disease, dia-
betes and coronary artery disease. Initial MELD score is at listing,
while final MELD score is the most recent value prior to transplant,
removal or end of the analysis period.
Table 3: Predictors of waiting list outcomes during the post-MELD
era, multivariate analysis
HR 95% CI
Transplant African American 0.99 0.93–1.04
Hispanic 0.80 0.77–0.83
MELD score (per unit)1 1.13 1.13–1.14
Primary diagnosis
Hepatitis C (vs. other) 0.96 0.93–0.99
Alcohol (vs. other) 0.85 0.81–0.89
HCC (vs. other) 3.36 3.14–3.59
Comorbidity 1.01 0.96–1.06
Blood group
B (vs. A) 1.20 1.14–1.25
AB (vs. A) 1.90 1.74–2.07
O (vs. A) 0.93 0.90–0.96
Age (per 10 years) 1.08 1.06–1.10
Male gender 1.20 1.16–1.24
Death/removal African American 0.85 0.71–1.01
Hispanic 0.92 0.84–1.01
MELD score (per unit)1 1.22 1.21–1.23
Primary diagnosis
Hepatitis C 1.18 1.08–1.28
(vs. other)
Alcohol (vs. other) 0.99 0.90–1.08
HCC (vs. other) 2.07 1.74–2.47
Comorbidity 1.16 1.02–1.32
Blood group
B (vs. A) 1.19 1.07–1.32
AB (vs. A) 1.02 0.80–1.31
O (vs. A) 1.12 1.03–1.22
Age (per 10 years) 1.44 1.38–1.51
Male gender 0.92 0.86–0.99
1MELD score treated as a time-varying covariate, reflecting
changes in MELD score over time.
Values in bold have a p-value <0.05.
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Figure 2: Racial and ethnic distribution of donation service
areas (DSAs) with median waiting times of ≤155 days versus
>155 days. Difference in proportion of Hispanics between the
DSA categories is statistically significant (p < 0.001).
Americans appear less likely to die/be removed from the
waiting list after adjusting for DSA-level effects (HR 0.81,
p = 0.001), while their hazard of transplantation remained
statistically not different from that of Caucasians as shown
in Table 4.
Discussion
This study has demonstrated that disparities in waitlist out-
comes exist for Hispanics during the post-MELD era, but
not for African Americans. After adjusting for differences in
severity of liver disease, African Americans appear to have
equal or better waitlist outcomes than Caucasians during
the post-MELD era. These findings are similar to those of a
recently published study by Moylan et al. (10) who despite
using different methodology and subject inclusion criteria
also found no significant disparities for African Americans
during the post-MELD era. The study by Moylan et al. did
not analyze outcomes for Hispanics, who represent the
largest minority group in the United States, nor did it ade-
quately adjust for geographic variations in organ supply.
Unfortunately, Hispanics have not fared as well during the
post-MELD era, and are less likely than Caucasians to re-
ceive a transplant despite adjustment for multiple potential
confounders. We found that all of the remaining disparities
Table 4: Predictors of waiting list outcomes during the post-MELD
era, adjusted for DSA-level effects
HR 95% CI
Transplant African American 1.01 0.97–1.06
Hispanic 1.00 0.96–1.05
MELD score (per unit)1 1.14 1.13–1.14
Primary diagnosis
Hepatitis C (vs. other) 0.99 0.96–1.03
Alcohol (vs. other) 0.90 0.86–0.94
HCC (vs. other) 3.86 3.60–4.15
Comorbidity 0.96 0.91–1.01
Blood group
B (vs. A) 1.20 1.15–1.26
AB (vs. A) 2.07 1.89–2.27
O (vs. A) 0.93 0.90–0.96
Age (per 10 years) 1.05 1.03–1.07
Male gender 1.23 1.19–1.27
Death/removal African American 0.81 0.72–0.92
Hispanic 0.97 0.89–1.05
MELD score (per unit)1 1.22 1.22–1.23
Primary diagnosis
Hepatitis C (vs. other) 1.20 1.12–1.28
Alcohol (vs. other) 0.99 0.91–1.08
HCC (vs. other) 2.20 1.84–2.62
Comorbidity 1.18 1.07–1.30
Blood group
B (vs. A) 1.17 1.07–1.29
AB (vs. A) 1.03 0.83–1.27
O (vs. A) 1.11 1.04–1.19
Age (per 10 years) 1.32 1.28–1.36
Male gender 0.93 0.87–0.99
1MELD score treated as a time-varying covariate, reflecting
changes in MELD score over time.
Values in bold have a p-value <0.05.
Results are from a fixed-effects multilevel model stratified by DSA.
for Hispanics could be explained by the fact that they live
in transplant regions with more severe organ shortage, as
measured by average time on the waiting list. Geographic
differences in availability of organs for transplantation have
been demonstrated in a number of other studies (9,18)
and may be partially due to clustering of transplant centers
in urban locations (19). To our knowledge, this is the first
study demonstrating that these geographic differences ex-
acerbate racial/ethnic disparities.
Several other findings in this study deserve mention. First,
we consistently identified that women are less likely to
receive a transplant and more likely to die/be removed
from the waiting list. This finding has been reported in
previous studies (10), but the reason for this disparity is
unknown. Secondly, we identified that African Americans
tend to have higher MELD scores than other racial/ethnic
groups, which may reflect later referral to transplant cen-
ters (1). After adjustment for MELD score and other con-
founders, African Americans appear less likely to die/be
removed than Caucasians; this difference became statis-
tically significant after additional adjustment for DSA-level
effects. We hypothesize that some of these findings for
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women and African Americans can be at least partially ex-
plained by the relative weight of creatinine in calculation
of the MELD score (20). It is known that women tend
to have worse renal function for a given creatinine, while
African Americans tend to have better renal function for a
given creatinine (21), so the mortality risk at a given MELD
score may not be equivalent across racial and gender
groups. This hypothesis should be formally tested in future
studies.
This study was limited by its observational nature, which
means that we cannot be certain that associations be-
tween geography and disparities are causative. Addition-
ally, patients’ race and ethnicity are designated by each in-
dividual transplant center in a nonsystematic fashion, and
the reliability of these designations is unknown. Finally, we
have only analyzed one stage of access to liver transplan-
tation, and cannot comment on disparities in referral and
listing. Since there are 40 000 deaths per year due to liver
disease in the United States (22) but only 6500 liver trans-
plants (23) performed, the referral and listing stages of the
liver transplant process are likely to be of equal or greater
importance than receipt of a liver transplant once on the
waiting list. Despite these limitations, this study provides
an understanding of the interactions between geographic
variations in organ supply and racial/ethnic disparities.
In conclusion, significant disparities in wait-list outcomes
exist for Hispanics during the post-MELD era, and these
disparities are attributable to geographic differences in or-
gan availability. These findings should serve to call atten-
tion to the fact that where one happens to live plays a
large role in the likelihood of receiving a transplant. Indeed,
these geographic variations are unjust for all patients, not
only Hispanics. Further research is needed to determine
whether these variations could be eliminated by changing
the allocation rules to foster increased interregional shar-
ing of organs, or whether a complete reorganization of
transplant regions is indicated (24).
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